McKinley Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

McKinley Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,340	Closed	-$26K	–	596
2016 Q2	$26K	Sell	1,340 -347,594	-100%	-$6.82M	﹤0.01%	361
2016 Q1	$7.19M	Sell	348,934 -40,197	-10%	-$792K	0.35%	80
2015 Q4	$7.99M	Buy	389,131 +131,921	+51%	+$2.53M	0.37%	66
2015 Q3	$4.4M	Buy	257,210 +51,506	+25%	+$941K	0.21%	133
2015 Q2	$3.83M	Buy	+205,704	New	+$3.81M	0.16%	157

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

McKinley Capital Management's VIVO Position: Q3 2016 in Review

McKinley Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2016, closing a stake of 1,340 shares — an estimated $26K sold.

McKinley Capital Management first reported a position in VIVO in Q2 2015 and held it in 5 quarters. The position peaked at $7.99M in Q4 2015. 173 funds tracked by Wall St. Rank hold VIVO as of Q3 2016.

McKinley Capital Management reported no remaining Meridian Bioscience Inc position as of Q3 2016 after selling out during the quarter.
McKinley Capital Management sold 1,340 Meridian Bioscience Inc shares in Q3 2016, an estimated $26K.
McKinley Capital Management first reported a position in Meridian Bioscience Inc in Q2 2015 and held it in 5 quarters.
McKinley Capital Management's Meridian Bioscience Inc position peaked at $7.99M in Q4 2015.
173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2016.

Based on McKinley Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.